Comparison

Simeprevir European Partner

Item no. TMO-T4686-10mg
Manufacturer TargetMol
CASRN 923604-59-5
Amount 10 mg
Quantity options 100 mg 1 mL x 10 mM (in DMSO) 10 mg 1 mL 25 mg 2 mg 50 mg 5 mg
Category
Type Molecules
Specific against other
Purity 0,9961
Citations 1.Lin TI, et al. In vitro activity and preclinical profile of TMC435350, a potent hepatitis C virus protease inhibitor.Antimicrob Agents Chemother. 2009 Apr;53(4):1377-85. Epub 2009 Jan 26.
Smiles COc1ccc2c(O[C@@H]3C[C@@H]4[C@@H](C3)C(=O)N(C)CCCC\C=C/[C@@H]3C[C@]3(NC4=O)C(=O)NS(=O)(=O)C3CC3)cc(nc2c1C)-c1nc(cs1)C(C)C
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Alias TMC435,TMC-435350,Olysio
Shipping Condition Cool pack
Available
Manufacturer - Targets
SARS-CoV|||HCV Protease
Shipping Temperature
Cool pack
Storage Conditions
-20
Molecular Weight
749.94
Description
Simeprevir (TMC435) is a potent HCV NS3/4A protease inhibitor, and inhibits HCV replication with EC50 of 8 nM.
Pathways
Microbiology/Virology|||Proteases/Proteasome

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 10 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close